Researchers found that regardless of donor pathology, outgrowth cultures produce pancreatic stellate cells that demonstrate consistent growth and protein secretion properties.
The University of Florida/Lake County Extension Office will put on “Small Steps/Big Rewards,” a four-part series about preventing and delaying diabetes.
The publication found that myxoma virus binds human T lymphocytes but does not enter and infect T cells until after activation.
Dr. Campbell-Thompson and her collaborators recently published a paper titled ‘Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 Diabetes.’ From the publication: “the study objective was to identify novel proteins that distinguish the pancreas from donors with T1D from the pancreas from…
UFDI helped establish this new collaborative cell hub, a source for qualified scientists to access somatic and pluripotent cell lines obtained from well-phenotyped type 1 diabetes patients.
Dr. Cherie Stabler’s work on using biomaterials to mimic regulatory T cells was featured in the latest volume of Science Translational Medicine.
UFDI researcher Dr. Martha Campbell-Thompson recently published an article on the Network for Pancreatic Organ Donors with Diabetes’s pancreatic tissue collection. Dr. Campbell highlights key findings from the nPOD collection.
Muscle strength may play a role in cardiometabolic disease. A new study led by Arch Mainous III, Ph.D., College of Public Health and Health Professions, finds that that grip strength measurements may be an effective way to identify cases of undiagnosed diabetes and high blood pressure. Read more.
The University of Florida is among the first sites nationwide to offer The EXTEND trial, a new clinical trial that will test the ability of the drug tocilizumab to slow disease progression and may help maintain natural insulin production in individuals with newly diagnosed Type 1 diabetes. For more information, contact the University of Florida Type 1 Diabetes TrialNet research team; 352-294-5761.
Dr. Desmond Schatz, medical director of the UF Diabetes Institute, was quoted in a recent story on new research being done that could prevent Type 1 diabetes. "We know so very little about the exact mechanisms that cause Type 1 diabetes, which complicates efforts to prevent it." Read more.
